 Shares of psychedelics company Mind Medicine Inc. MNMD, 6.43 slid 35.6 in premarket trade Wednesday, after the company priced a dilutive secondary offering of 7.1 million shares. The offering priced at 4.25 a share, below the stocks closing price Tuesday of 6.12. 